Creatinine, eGFR, proteinuria, finerenone, CKD, T2D

Overview
There is currently a lack of awareness among general practitioners treating chronic kidney disease (CKD) regarding the importance of managing associated cardiovascular (CV) events. CKD patients who are considered high-risk and do not receive appropriate specialized treatment represent a missed opportunity for the delivery of interventions to reduce CKD progression. Join the experts in this multidisciplinary program to learn best practices, and hear about a new clinical trial looking at the link between heart failure and cardiovascular events in this high-risk patient population.
Disclosure of Relevant Financial Relationships
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Host:
Michael Weber, MD
Professor of Medicine
SUNY Downstate Medical Center
Brooklyn, NY
Dr. Weber has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: Alnylam, Idorsia
Faculty:
M. Luiza Caramori, MD, PhD, MSc
Staff Physician
Department of Endocrinology and Metabolism
Cleveland Clinic Foundation
Cleveland, OH
Dr. Caramori has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Research: Bayer, Eli Lilly
Consulting Fees: Bayer AG
Peter Rossing, MD, DMSc
Head of Complications Research
Chief Physician
Steno Diabetes Center
Copenhagen, Denmark
No relevant financial relationships have been reported at this time.
Reviewers/Content Planners/Authors:
- Cindy Davidson has nothing to disclose.
- Kathleen Sheridan, PhD, has nothing to disclose.
Learning Objectives
After participating in this educational activity, participants should be better able to:
- Increase the ability to recognize the CV signs and symptoms associated with CKD
- Discuss patients who are “at high risk” to implement timely interventions
- Discuss the clinical application of the latest guidance and clinical evidence to implement strategies that improve adherence and clinical outcomes in patients with CKD
Target Audience
This activity has been designed to meet the educational needs of primary care physicians and nephrologists as well as all other physicians, physician assistants, nurse practitioners, nurses, pharmacists, and healthcare providers involved in managing patients with chronic kidney disease.
Accreditation and Credit Designation Statements
In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Global Learning Collaborative (GLC) designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 1.0 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until July 31. 2025. PAs should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 1.0 contact hour/0.1 CEUs of pharmacy contact hours.
The Universal Activity Number for this program is JA0006235-0000-24-097-H01-P. This learning activity is knowledge-based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net). 
Provider(s)/Educational Partner(s)
It’s about time! Today’s on-the-go learners have minutes to spend on education instead of hours. Total CME, LLC, is an award-winning, global healthcare education company that strategically pioneers methodology, initiatives, and platforms to meet these time-limited needs. Unlike other medical education companies, Total CME employs a microlearning approach and platform to create outcome-based curricula that motivates HCPs to engage in self-directed point-of-care learning that impacts change in real time. Even while reaching the largest global distribution, we provide the most personalized, seamless learner experience. We’re meeting our busy learners where they are so they can focus on what they want when they need it, ultimately leading to behavior changes that impact clinical practice and empower patients in their own care.
Commercial Support
This activity is supported by an independent educational grant from Bayer HealthCare Pharmaceuticals Inc.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Total CME. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to access a site outside of Total CME you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.
System Requirements
- Supported Browsers (2 most recent versions):
- - Google Chrome for Windows, Mac OS, iOS, and Android
  - Apple Safari for Mac OS and iOS
  - Mozilla Firefox for Windows, Mac OS, iOS, and Android
  - Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date: 07/31/2024
Expiration Date: 07/31/2025